ELEVANCE HEALTH, INC. (ELV)

Import this data to Google Sheets with:

=jivedata("ELV","financials")

Full statements spill as a table. For one cell: =jivedata("ELV","Revenue") or =jivedata("ELV","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ELEVANCE HEALTH, INC.

ELV • CIK 0001156039

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$7,715,000	$7,904,000	$6,710,000	$6,250,000
Income Tax Expense (Benefit)	$1,724,000	$1,933,000	$1,049,000	$1,147,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$5,991,000	$5,971,000	$5,661,000	$5,103,000
Net Income (Loss) Attributable to Noncontrolling Interest	$4,000	$-9,000	$-1,000	$-36,000
Net Income (Loss) Attributable to Parent	$5,987,000	$5,980,000	$5,662,000	$5,139,000
Premiums Earned, Net	$142,854,000	$144,166,000	$164,639,000	$164,697,000
Net Investment Income	$1,825,000	$2,051,000	$2,194,000	$2,999,000
Gain (Loss) on Disposition of Business	—	$201,000	$0	$0
Revenues	$171,340,000	$177,011,000	$199,125,000	$201,831,000
Policyholder Benefits and Claims Incurred, Net	$124,330,000	$127,567,000	$148,223,000	$148,483,000
Cost of Goods and Services Sold	$17,293,000	$19,750,000	$21,178,000	$22,117,000
Selling, General and Administrative Expense	$20,087,000	$20,025,000	$20,984,000	$23,044,000
InterestExpenseNonoperating	—	$1,185,000	$1,402,000	$1,445,000
Amortization of Intangible Assets	$885,000	$580,000	$628,000	$492,000
Benefits, Losses and Expenses	$163,625,000	$169,107,000	$192,415,000	$195,581,000
Weighted Average Number of Shares Outstanding, Basic	235,900,000	231,700,000	224,000,000	216,800,000
Weighted Average Number Diluted Shares Outstanding Adjustment	1,500,000	1,200,000	600,000	800,000
Weighted Average Number of Shares Outstanding, Diluted	237,400,000	232,900,000	224,600,000	217,600,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	800,000	—	—	800,000
Operating Income (Loss)	$8,499,000	$7,862,000	$7,199,000	$5,427,000
Other Income	$7,903,000	—	—	$7,903,000
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	—	—	$6,710,000	$6,710,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$6,526,000	$8,288,000	$9,491,000	$10,348,000
Debt Securities, Available-for-sale, Current	$29,614,000	$25,201,000	$25,884,000	$25,347,000
Equity Securities, FV-NI	$229,000	$1,192,000	$740,000	$2,151,000
Property, Plant and Equipment, Net	$4,359,000	$4,652,000	$4,679,000	$4,613,000
Premiums Receivable, Net	$7,902,000	$8,011,000	$10,073,000	$10,686,000
Goodwill	$25,317,000	$28,277,000	$28,344,000	$28,343,000
Intangible Assets, Net (Excluding Goodwill)	$10,273,000	$12,094,000	$11,200,000	$10,877,000
Other Receivables	$5,405,000	$6,016,000	$6,307,000	$7,610,000
Other Assets, Noncurrent	$1,967,000	$2,140,000	$2,310,000	$2,725,000
Other Assets, Current	$5,795,000	$4,700,000	$5,344,000	$6,105,000
Assets	$108,928,000	$116,889,000	$121,494,000	$127,801,000
Assets Held-for-sale, Not Part of Disposal Group, Current	—	$490,000	$0	$0
Assets, Current	$60,029,000	$58,942,000	$63,001,000	$68,524,000
Debt Securities, Available-for-sale, Noncurrent	$876,000	$1,035,000	$1,121,000	$1,211,000
Other Long-term Investments	$6,107,000	$9,749,000	$10,839,000	$11,508,000
Liabilities, Current	$41,791,000	$40,581,000	$41,035,000	$46,662,000
Long-term Debt, Excluding Current Maturities	$23,246,000	$29,218,000	$30,797,000	$30,382,000
Liability for Future Policy Benefit, before Reinsurance	$778,000	$190,000	$145,000	$145,000
Deferred Income Tax Liabilities, Net	$1,970,000	$2,148,000	$2,110,000	$1,487,000
Other Liabilities, Noncurrent	$1,738,000	$3,326,000	$3,381,000	$4,476,000
Liabilities	$69,523,000	$75,463,000	$77,468,000	$83,007,000
Liability for Claims and Claims Adjustment Expense	$16,111,000	$15,746,000	$17,084,000	$18,438,000
Other Policyholder Funds	$5,600,000	$4,204,000	$3,632,000	$2,635,000
Unearned Premiums	$1,402,000	$1,508,000	$1,493,000	$1,637,000
Accounts Payable and Accrued Liabilities, Current	$6,910,000	$6,927,000	$7,322,000	$8,315,000
Short-term Debt	$225,000	$365,000	$150,000	$0
Long-term Debt, Current Maturities	$1,649,000	$1,649,000	$1,099,000	$375,000
Other Liabilities, Current	$9,894,000	$10,029,000	$10,255,000	$15,262,000
Disposal Group, Including Discontinued Operation, Liabilities, Current	—	$153,000	$0	$0
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$2,000	$2,000	$2,000	$2,000
Additional Paid in Capital	$8,868,000	$8,911,000	$8,938,000	$8,987,000
Retained Earnings (Accumulated Deficit)	$31,749,000	$33,549,000	$35,393,000	$37,368,000
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-1,313,000	$-1,147,000	$-451,000	$-1,676,000
Stockholders' Equity Attributable to Parent	$39,306,000	$41,315,000	$43,882,000	$44,681,000
Stockholders' Equity Attributable to Noncontrolling Interest	$99,000	$111,000	$144,000	$113,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$39,405,000	$41,426,000	$44,026,000	$44,794,000
Debt Securities, Available-for-sale, Amortized Cost, Current	$30,446,000	$25,879,000	$25,773,000	$26,806,000
Debt Securities, Available-for-sale, Allowance for Credit Loss, Current	$4,000	$6,000	$21,000	$60,000
Debt Securities, Available-for-sale, Amortized Cost, Noncurrent	$890,000	$1,049,000	$1,116,000	$1,272,000
Preferred Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	900,000,000	900,000,000	900,000,000	900,000,000
Common Stock, Shares, Issued	233,071,088	227,479,695	220,723,898	216,113,946
Derivative, Amount of Hedged Item	—	$29,218,000	$30,797,000	$30,797,000
Derivative Liability	—	—	$28,000	$28,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$5,991,000	$5,971,000	$5,661,000	$5,103,000
Net Cash Provided by (Used in) Operating Activities	$8,061,000	$5,808,000	$4,290,000	$7,596,000
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-1,000	$-6,000	$-5,000	$-20,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-861,000	$1,828,000	$1,203,000	$1,635,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$6,526,000	$8,288,000	$9,491,000	$11,648,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations	—	$66,000	$0	$0
Payments to Acquire Investments	$16,236,000	$17,986,000	$15,026,000	$16,703,000
Gain (Loss) on Disposition of Business	—	$201,000	$0	$0
Income (Loss) from Equity Method Investments	$-33,000	$1,000	$398,000	$1,255,000
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	$2,940,000	$2,025,000	$1,771,000	$1,949,000
Depreciation, Amortization and Accretion, Net	$1,745,000	$1,393,000	$1,546,000	$1,489,000
Increase (Decrease) in Collateral Held under Securities Lending	$-78,000	$-73,000	$385,000	$182,000
Deferred Income Tax Expense (Benefit)	$-602,000	$-374,000	$-279,000	$-588,000
Payments to Acquire Businesses, Net of Cash Acquired	$1,552,000	$4,809,000	$-88,000	$-35,000
Asset Impairment Charges	$446,000	$103,000	$108,000	$108,000
Proceeds from Divestiture of Businesses, Net of Cash Divested	—	$363,000	$0	$0
Share-based Payment Arrangement, Noncash Expense	$289,000	$191,000	$276,000	$240,000
Payments to Acquire Property, Plant, and Equipment	$1,296,000	$1,256,000	$1,116,000	$1,082,000
Payments for (Proceeds from) Other Investing Activities	$102,000	$124,000	$0	$-45,000
Net Cash Provided by (Used in) Investing Activities	$-5,572,000	$-5,167,000	$-1,344,000	$-3,006,000
Proceeds from Issuance of Long-term Debt	$2,574,000	$7,710,000	$2,991,000	$-3,000
Repayments of Long-term Debt	$1,909,000	$1,650,000	$2,147,000	$747,000
Proceeds from Short-term Debt	$225,000	$275,000	$1,505,000	$1,340,000
Repayments of Short-term Debt	$265,000	$135,000	$1,720,000	$1,520,000
Increase (Decrease) in Securities Lending Payable	$-77,000	$-75,000	$386,000	$183,000
Increase (Decrease) in Outstanding Checks, Financing Activities	$114,000	$-638,000	$1,312,000	$1,335,000
Payments for Repurchase of Common Stock	$2,676,000	$2,900,000	$2,605,000	$2,159,000
Payments of Dividends	$1,395,000	$1,508,000	$1,529,000	$1,499,000
Proceeds from Stock Plans	—	$221,000	$79,000	$79,000
Payment, Tax Withholding, Share-based Payment Arrangement	$99,000	$109,000	$32,000	$37,000
Proceeds from (Payments for) Other Financing Activities	$7,000	$2,000	$22,000	$26,000
Net Cash Provided by (Used in) Financing Activities	$-3,349,000	$1,193,000	$-1,738,000	$-2,935,000
Increase (Decrease) in Receivables	$1,762,000	$683,000	$2,526,000	$1,971,000
Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI	$79,000	$78,000	$0	$-70,000
Increase (Decrease) in Other Operating Assets	$675,000	$-824,000	$-57,000	$802,000
Increase (Decrease) in Insurance Liabilities	$147,000	$-1,840,000	$228,000	$1,459,000
Increase (Decrease) in Deferred Revenue	$290,000	$-113,000	$-15,000	$-194,000
Increase (Decrease) in Accounts Payable and Other Operating Liabilities	$1,640,000	$-272,000	$-720,000	$3,105,000
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable	$-103,000	$404,000	$-297,000	$631,000
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$-7,000	$-39,000	$4,000	$38,000
Proceeds from Stock Options Exercised	$152,000	$154,000	$51,000	$118,000

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ELV","financials")

Full statements spill as a table. For one cell: =jivedata("ELV","Revenue") or =jivedata("ELV","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.